Method Development for Simultaneously Determining Indomethacin and Nicotinamide in New Combination in Oral Dosage Formulations and Co-Amorphous Systems Using Three UV Spectrophotometric Techniques

<div>The zero-order UV absorption spectra of (1) nicotinamide 20 <i>μ</i>g/mL (red), (2) indomethacin 20 <i>μ</i>g/mL (blue), and the dosage formulations of indomethacin with the same concentration ((3) immediate-release capsules (green), and (4) sustained-release ones (purple)).</div>

International Journal of Analytical Chemistry

fig3

Figure 3

Figure 3: Method Development for Simultaneously Determining Indomethacin and Nicotinamide in New Combination in Oral Dosage Formulations and Co-Amorphous Systems Using Three UV Spectrophotometric Techniques 

Figure 3 | Method Development for Simultaneously Determining Indomethacin and Nicotinamide in New Combination in Oral Dosage Formulations and Co-Amorphous Systems Using Three UV Spectrophotometric Techniques 